National UK guidelines for the management of paediatric craniopharyngioma

HW Gan, P Morillon, A Albanese, K Aquilina… - The Lancet Diabetes & …, 2023 - thelancet.com
Although rare, craniopharyngiomas constitute up to 80% of tumours in the hypothalamic–
pituitary region in childhood. Despite being benign, the close proximity of these tumours to …

[HTML][HTML] Current approaches to craniopharyngioma management

MJ Diaz, SH Kwak, KT Root, A Fadil… - Frontiers in Bioscience …, 2022 - imrpress.com
Craniopharyngiomas (CP) are rare noncancerous brain tumors located in the skull base. To
date, CP remain challenging-to-resect tumors, owing to their difficult location and invasive …

Molecular analyses reveal inflammatory mediators in the solid component and cyst fluid of human adamantinomatous craniopharyngioma

AM Donson, J Apps, AM Griesinger… - … of Neuropathology & …, 2017 - academic.oup.com
Pediatric adamantinomatous craniopharyngioma (ACP) is a highly solid and cystic tumor,
often causing substantial damage to critical neuroendocrine structures such as the …

Response assessment in pediatric craniopharyngioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) Working Group

LM Hoffman, C Jaimes, K Mankad, DM Mirsky… - Neuro …, 2023 - academic.oup.com
Background Craniopharyngioma is a histologically benign tumor of the suprasellar region
for which survival is excellent but quality of life is often poor secondary to functional deficits …

Approach to the patient: New era emerges for craniopharyngioma management

AG Hayes, B Jonker, C Teng, C Lemech… - The Journal of …, 2024 - academic.oup.com
Papillary craniopharyngioma (PCP) and adamantinomatous craniopharyngioma (ACP) are
distinct, slow-growing tumors of the suprasellar region. Their location, composition, and …

Management of craniopharyngiomas

N Karavitaki - Journal of endocrinological investigation, 2014 - Springer
Craniopharyngiomas are rare epithelial tumours arising along the path of the
craniopharyngeal duct. Their pathogenesis remains uncertain and they can present with a …

Targeted therapy in the management of modern craniopharyngiomas

M Reyes, M Taghvaei, S Yu, A Sathe, S Collopy… - 2022 - jdc.jefferson.edu
Background: The proximity of craniopharyngiomas (CPs) to critical neurovascular structures
can lead to a host of neurologic and endocrine complications that lead to difficulty with …

Craniopharyngiomas

R Hamblin, G Tsermoulas, N Karavitaki - La Presse Médicale, 2021 - Elsevier
Craniopharyngiomas are rare epithelial tumours situated primarily in the sellar/parasellar
region, occurring along the path of the craniopharyngeal duct. Whilst classed as …

Phase II study of peginterferon alpha-2b for patients with unresectable or recurrent craniopharyngiomas: a Pediatric Brain Tumor Consortium report

S Goldman, IF Pollack, RI Jakacki, CA Billups… - Neuro …, 2020 - academic.oup.com
Background Craniopharyngiomas account for approximately 1.2–4% of all CNS tumors.
They are typically treated with a combination of surgical resection and focal radiotherapy …

[HTML][HTML] Treatment options for pediatric craniopharyngioma

GD Reddy, D Hansen, A Patel, Y Lin… - Surgical neurology …, 2016 - ncbi.nlm.nih.gov
SNI: Pediatric Neurosurgery 2016, Vol 7: Suppl 6-A Supplement to Surgical Neurology
International an enlarging suprasellar cyst for intermittent as‑needed drainage of …